The Opioid-Prescribing in Dermatology Workgroup determined that 10% of patients or less undergoing 87 common dermatological procedures require postoperative opioid management at discharge.

Forty members of the American College of Mohs Surgery, American Academy of Dermatology and American Vein and Lymphatic Society participated in the workgroup. All had board certification in dermatology and an active DEA license.